ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients.

Keri A Streby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.